X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (308) 308
humans (301) 301
female (280) 280
oncology (280) 280
middle aged (195) 195
aged (182) 182
risk factors (156) 156
breast cancer (142) 142
postmenopausal women (140) 140
postmenopause (116) 116
risk (101) 101
health aspects (97) 97
incidence (80) 80
women (76) 76
breast neoplasms - epidemiology (75) 75
womens health (75) 75
cancer (72) 72
follow-up studies (61) 61
proportional hazards models (61) 61
women's health (61) 61
abridged index medicus (60) 60
estrogen (60) 60
medicine, general & internal (56) 56
public, environmental & occupational health (56) 56
hormone replacement therapy (55) 55
tamoxifen (55) 55
united states - epidemiology (55) 55
research (54) 54
mortality (50) 50
breast neoplasms - drug therapy (49) 49
clinical trials (48) 48
breast-cancer (46) 46
article (45) 45
prospective studies (45) 45
breast neoplasms - prevention & control (44) 44
mammography (44) 44
menopause (44) 44
randomized controlled trials as topic (44) 44
breast neoplasms - pathology (43) 43
prevention (42) 42
risk assessment (39) 39
survival (39) 39
estrogen replacement therapy - adverse effects (37) 37
cohort studies (36) 36
randomized controlled-trial (36) 36
epidemiology (32) 32
estrogen plus progestin (32) 32
health risk assessment (31) 31
body mass index (29) 29
metaanalysis (29) 29
prognosis (29) 29
tamoxifen - therapeutic use (29) 29
hormone therapy (28) 28
obesity (28) 28
obstetrics & gynecology (28) 28
cohort (27) 27
estrogens, conjugated - adverse effects (26) 26
post-menopause (26) 26
adult (25) 25
diet (25) 25
replacement therapy (25) 25
trial (25) 25
breast neoplasms - etiology (24) 24
care and treatment (24) 24
confidence intervals (23) 23
healthy postmenopausal women (23) 23
health (22) 22
hysterectomy (22) 22
male (22) 22
randomized-trial (22) 22
case-control studies (21) 21
chemotherapy, adjuvant (21) 21
clinical-trial (21) 21
double-blind method (21) 21
nutrition & dietetics (21) 21
surveys and questionnaires (21) 21
antineoplastic agents, hormonal - therapeutic use (20) 20
aromatase inhibitors - therapeutic use (20) 20
breast neoplasms - chemically induced (20) 20
diagnosis (20) 20
estrogen replacement therapy - methods (20) 20
estrogens, conjugated - administration & dosage (20) 20
follow-up (20) 20
odds ratio (20) 20
association (19) 19
clinical trials as topic (19) 19
conjugated equine estrogens (19) 19
quality-of-life (19) 19
therapy (19) 19
time factors (19) 19
treatment outcome (19) 19
breast (18) 18
breast neoplasms - mortality (18) 18
chemotherapy (18) 18
colorectal cancer (18) 18
disease (18) 18
endometrial cancer (18) 18
estrogens (18) 18
endocrine therapy (17) 17
estrogen replacement therapy (17) 17
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 03/2017, Volume 35, Issue 7, pp. 702 - 704
Journal Article
Cancer Research, ISSN 0008-5472, 12/2011, Volume 71, Issue 24 Supplement, pp. P3 - P3-11-02
Journal Article
Journal Article
Cancer Research, ISSN 0008-5472, 12/2010, Volume 70, Issue 24 Supplement, pp. S6 - S6-1
Journal Article
The Lancet Oncology, ISSN 1470-2045, 01/2018, Volume 19, Issue 1, pp. 13 - 15
Journal Article
Journal Article
BREAST CANCER RESEARCH AND TREATMENT, ISSN 0167-6806, 06/2017, Volume 163, Issue 3, pp. 633 - 634
Journal Article
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 04/2019, Volume 37, Issue 11, pp. 858 - 858
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2004, Volume 350, Issue 10, pp. 991 - 1004
Journal Article
JAMA - Journal of the American Medical Association, ISSN 0098-7484, 2013, Volume 310, Issue 13, pp. 1353 - 1368
IMPORTANCE Menopausal hormone therapy continues in clinical use but questions remain regarding its risks and benefits for chronic disease prevention. OBJECTIVE... 
BREAST-CANCER | INSOMNIA RATING-SCALE | MEDICINE, GENERAL & INTERNAL | REPLACEMENT THERAPY | PLACEBO-CONTROLLED TRIAL | QUALITY-OF-LIFE | ESTROGEN PLUS PROGESTIN | CORONARY-HEART-DISEASE | MILD COGNITIVE IMPAIRMENT | POSTMENOPAUSAL WOMEN | CONJUGATED EQUINE ESTROGEN | United States - epidemiology | Follow-Up Studies | Humans | Middle Aged | Coronary Disease - epidemiology | Risk | Hormone Replacement Therapy - adverse effects | Pulmonary Embolism - epidemiology | Estrogens - adverse effects | Medroxyprogesterone Acetate - adverse effects | Postmenopause | Female | Stroke - epidemiology | Drug Therapy, Combination | Breast Neoplasms - epidemiology | Colorectal Neoplasms - epidemiology | Estrogens, Conjugated (USP) - administration & dosage | Treatment Outcome | Endometrial Neoplasms - epidemiology | Hip Fractures - epidemiology | Breast Neoplasms - prevention & control | Coronary Disease - prevention & control | Quality of Life | Aged | Medroxyprogesterone Acetate - administration & dosage | Estrogens, Conjugated (USP) - adverse effects | Estrogens - administration & dosage | Women | Care and treatment | Research | Hormone therapy | Health aspects | Menopause | Womens health | Estrogen | Endocrine therapy | Clinical trials | Cardiovascular disease | Breast cancer | Progesterone | Index Medicus | Abridged Index Medicus
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.